MicroBase Technology

MicroBase Technology Financial Debt Ratio

The Financial Debt Ratio of MicroBase Technology (3184.TWO) as of Oct 30, 2026 is 2.80 %. In the previous year, Financial Debt Ratio was 3.35 % — a change of -16.57% (lower).

Financial Debt Ratio

2.80 %

YoY

-16.57%

Last updated:

Financial Debt Ratio of MicroBase Technology is 2024 2.80 % . Financial Debt Ratio of MicroBase Technology was 2023 3.35 % . It decreases by -16.57% lower compared to the previous year.

The MicroBase Technology Financial Debt Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Debt Ratio
Date
Financial Debt Ratio
Jan 1, 2016
12.15 TWD
Jan 1, 2017
20.09 TWD
Jan 1, 2018
25.08 TWD
Jan 1, 2020
19.07 TWD
Jan 1, 2021
15.19 TWD
Jan 1, 2022
12.55 TWD
Jan 1, 2023
3.35 TWD
Jan 1, 2024
2.80 TWD
The MicroBase Technology Financial Debt Ratio history
YEARFinancial Debt RatioYoY
2.80 %-16.57%
3.35 %-73.31%
12.55 %-17.38%
15.19 %-20.34%
19.07 %-23.95%
25.08 %+24.82%
20.09 %+65.42%
12.15 %+15.44%
10.52 %-43.98%
18.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MicroBase Technology Stock analysis

What does MicroBase Technology do? MicroBase Technology Corp, listed on the Taiwan Stock Exchange under ticker 3184.TWO, is a health care company headquartered in Taoyuan, Taiwan. The company has 48 employees and completed its initial public offering on April 18, 2013. MicroBase Technology Corp engages in the production, planning, and maintenance of medical equipment. The company's product portfolio includes the Inkjet Printer Nozzle Plate, Microneedle Patch, Aerosol Generator Head, Nebulizer, and Soft Mist Inhaler, among others. These products are distributed both domestically within Taiwan and internationally to overseas markets. The company operates within the health care sector, focusing on medical equipment solutions. MicroBase Technology Corp maintains a website at https://microbasetech.com/ for further information. The company's operations are centered around the development and distribution of specialized medical devices, with an emphasis on both local and global market reach. As a publicly traded entity, it provides transparency through its financial disclosures and corporate governance practices. The firm's activities are primarily conducted in Taoyuan, Taiwan, reflecting its regional operational base. MicroBase Technology Corp's business model involves the manufacturing and maintenance of medical equipment, targeting both domestic and international customers through its product offerings. MicroBase Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MicroBase Technology stock

Financial Debt Ratio of MicroBase Technology is 2.80 % in 2024.

Financial Debt Ratio of MicroBase Technology changed from 3.35 % to 2.80 %, representing a -16.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Debt Ratio MicroBase Technology since 2006 – with annual values, charts, and detailed analysis.

The financial debt ratio measures interest-bearing financial debt as a percentage of total assets. It isolates funded debt from trade and other non-financial obligations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Debt Ratio's MicroBase Technology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — MicroBase Technology

All Key Metrics — MicroBase Technology